Similar articles

• Regulation of catecholamine turnover by variations of enzyme levels.

  Pletscher A. Pletscher A. Pharmacol Rev. 1972 Jun;24(2):225-32. Pharmacol Rev. 1972. PMID: 4404611 Review. No abstract available.
• Molecular geometry and adrenergic drug activity.

  Patil PN, Miller DD, Trendelenburg U. Patil PN, et al. Pharmacol Rev. 1974 Dec;26(4):323-92. Pharmacol Rev. 1974. PMID: 4156804 Review. No abstract available.
• [Inhibitors of catecholamine biosynthesis (review of the literature)].

  Frantsuzova SB. Frantsuzova SB. Farmakol Toksikol. 1973 Sep-Oct;36(5):624-8. Farmakol Toksikol. 1973. PMID: 4150865 Review. Russian. No abstract available.
• [Effects of alpha-methyldopa on systolic pressure and activities of tyrosine hydroxylase, dopamine-beta-hydroxylase and phenethanolamine-N-methyl-transferase in nervous system of spontaneously hypertensive rats].

  Ming L, Renaud B. Ming L, et al. Zhongguo Yao Li Xue Bao. 1985 Dec;6(4):244-8. Zhongguo Yao Li Xue Bao. 1985. PMID: 2876577 Chinese. No abstract available.
• Regulation of catecholamine biosynthetic enzymes.

  Ciaranello RD. Ciaranello RD. Psychopharmacol Bull. 1979 Jan;15(1):59. Psychopharmacol Bull. 1979. PMID: 33411 No abstract available.